Skip to main content

Newsroom

Latest News

July 3, 2015

WASHINGTON – Yesterday, the House Committee on Energy and Commerce Republicans filed a substitute amendment to H.R. 6, the 21st Century Cures Act. In a last minute change, the new language fell $1.25 billion short in mandatory funding for research at the National Institutes of Health (NIH).

June 26, 2015

WASHINGTON, DC – U.S. Rep. Diana DeGette (CO-01) and Energy and Commerce Committee Chairman Fred Upton (MI-06) will headline a panel on Saturday with former Food and Drug Administration Commissioner Margaret Hamburg at the Aspen Ideas Festival 2015: Spotlight Health.

June 26, 2015

Washington – U.S. Rep. Diana DeGette (CO-01) released the following statement after the U.S. Supreme Court affirmed the right to marry:

"Finally, every loving couple in the United States may choose to express their commitment in marriage and be assured of its legal benefits and responsibilities. This is a proud moment in our ongoing march towards full equality.

"I was particularly touched by Justice Kennedy's observation about the children of same sex couples, who have borne the burden of the inequality of their parents' relationships, observing:

June 25, 2015

WASHINGTON - Today, members of Colorado's Congressional delegation introduced a bill to create two new U.S. District Court judgeships for the District of Colorado. Colorado's population has grown 66 percent in the three decades since a new judgeship was added, precipitating a judicial crisis. Rep. Diana DeGette (CO-01) introduced the legislation and was joined by Reps. Jared Polis (CO-02), Scott Tipton (CO-03), Doug Lamborn (CO-05), Mike Coffman (CO-06), and Ed Perlmutter (CO-07).

June 24, 2015

WASHINGTON- U.S. Rep. Diana DeGette (CO-01) offered strong support for Homeland Security Secretary Jeh Johnson's decision to limit the detainment of mothers and children involved in deportation proceedings in jail-like facilities and called for an end to family detention altogether.

June 17, 2015

WASHINGTON – Today, U.S. Rep Diana DeGette worked with House Energy and Commerce colleagues on both sides of the aisle to protect the freedom of the open and global internet.

June 15, 2015

WASHINGTON — Many have lamented the harsh and meaningless debates in Washington. As lawmakers and public servants ourselves, we all too often share in that frustration. That is why we are especially excited to have formed a bipartisan partnership to support innovation in medical research that helps deliver treatments and cures to the patients who need them.

June 10, 2015

Congresswoman Diana DeGette stood in the workout room Monday at Denver Indian Health and Family Services to announce legislation aimed at curbing the devastating rates of diabetes in communities of color.

"According to Centers for Disease Control nearly half – nearly half – of all minority children born in 2000 will develop diabetes at some point in their lifetime," said DeGette. "These disparities need to be addressed immediately."

June 10, 2015

Lunch visitors to the Humboldt restaurant today did a double take when they saw former President Clinton dining with Bono.

Among those lucky enough to be there and talk to the pair: Rep. Diana DeGette. The Denver congresswoman was catching up with the head of a nonprofit over lunch when the two celebrities walked in.

Clinton is in town for the Clinton Global Initiative, which started Monday at the Sheraton in downtown Denver. Bono is a singer with U2, which performed at the Pepsi Center Saturday.

June 8, 2015

WASHINGTON, DC—U.S. Rep. Diana DeGette (CO-01) joined colleagues on the House Energy and Commerce Committee to urge the U.S. Food and Drug Administration (FDA) to compel manufacturers to more clearly convey the serious risks associated with the use of opioid pain relievers. Twenty-two Democratic members of the Committee, led by Rep. DeGette, Oversight and Investigations Subcommittee Ranking Member, as well as full Committee Ranking Member Frank Pallone, Jr. (D-NJ) and Health Subcommittee Ranking Member Gene Green (D-TX), wrote to FDA Acting Commissioner Dr.